Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 86

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 86
---
2026                                     |     |        |          |     |  6,226 |         |     |  5,127 | 3/1/2025                                       |     |        |          |     | 1,709 |         |     |        |                                                                            |     |        |         |     |        |         |     |        |
|                  |     |        | 3/1/2027                                     |     |        |          |     |  6,226 |         |     |        | 3/1/2026                                       |     |        |          |     | 1,709 |         |     |        |                                                                            |     |        |         |     |        |         |     |        |
|                  |     |        |                                              |     |        |          |     |        |         |     |        | 3/1/2027                                       |     |        |          |     | 1,709 |         |     |        |                                                                            |     |        |         |     |        |         |     |        |
| Total            |     |        |                                              |     |        |          |     |        |         |     | 41,004 |                                                |     |        |          |     |       |         |     | 26,710 |                                                                            |     |        |         |     |        |         |     | 20,862 |

| 88 |     | The Cigna Group| 2025 Notice of Annual Meeting of Shareholders and Proxy Statement |

| COMPENSATION MATTERS |

i. These columns include unvested restricted stock and SPSs granted for the 2022–2024 performance period. The number of SPSs reported in these columns reflects the shares vested in March 2025 for the 2022–2024 performance period at their actual payout percentage. As of December 31, 2024, the relevant performance conditions had been satisfied, but the awards were not fully vested until payout in March 2025.

ii. These columns include unvested SPSs granted for the 2023–2025 and 2024–2026 performance periods. The SPS awards are not fully vested until paid in the year following the close of the three-year performance period. The People Resources Committee determines payout, if any, in the year of vesting based on achievement of three-year performance goals. It is not possible to determine SPS award